FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3004603875> ?p ?o ?g. }

• W3004603875 endingPage "549" @default.
• W3004603875 startingPage "535" @default.
• W3004603875 abstract "Gastric cancer (GC) remains the third leading cause of cancer-related death despite several improvements in targeted therapy. There is therefore an urgent need to investigate new treatment strategies, including the identification of novel biomarkers for patient stratification. In this study, we evaluated the effect of FDA-approved kinase inhibitors on GC. Through a combination of cell growth, migration and invasion assays, we identified dasatinib as an efficient inhibitor of GC proliferation. Mass-spectrometry-based selectivity profiling and subsequent knockdown experiments identified members of the SRC family of kinases including SRC, FRK, LYN and YES, as well as other kinases such as DDR1, ABL2, SIK2, RIPK2, EPHA2, and EPHB2 as dasatinib targets. The expression levels of the identified kinases were investigated on RNA and protein level in 200 classified tumor samples from patients, who had undergone gastrectomy, but had received no treatment. Levels of FRK, DDR1 and SRC expression on both mRNA and protein level were significantly higher in metastatic patient samples regardless of the tumor stage, while expression levels of SIK2 correlated with tumor size. Collectively, our data suggest dasatinib for treatment of GC based on its unique property, inhibiting a small number of key kinases (SRC, FRK, DDR1 and SIK2), highly expressed in GC patients." @default.
• W3004603875 created "2020-02-14" @default.
• W3004603875 creator A5003613402 @default.
• W3004603875 creator A5005215250 @default.
• W3004603875 creator A5006136258 @default.
• W3004603875 creator A5017132592 @default.
• W3004603875 creator A5018890363 @default.
• W3004603875 creator A5022557737 @default.
• W3004603875 creator A5028472487 @default.
• W3004603875 creator A5039349687 @default.
• W3004603875 creator A5058082024 @default.
• W3004603875 creator A5059321865 @default.
• W3004603875 creator A5062075072 @default.
• W3004603875 creator A5068600717 @default.
• W3004603875 creator A5070227121 @default.
• W3004603875 creator A5073227512 @default.
• W3004603875 creator A5078523345 @default.
• W3004603875 creator A5091138255 @default.
• W3004603875 date "2020-02-04" @default.
• W3004603875 modified "2023-10-18" @default.
• W3004603875 title "Identification of molecular targets for the targeted treatment of gastric cancer using dasatinib" @default.
• W3004603875 cites W1495280521 @default.
• W3004603875 cites W1536452773 @default.
• W3004603875 cites W1608710587 @default.
• W3004603875 cites W1991541715 @default.
• W3004603875 cites W2000868207 @default.
• W3004603875 cites W2008322008 @default.
• W3004603875 cites W2009785633 @default.
• W3004603875 cites W2019565481 @default.
• W3004603875 cites W2026542427 @default.
• W3004603875 cites W2034269086 @default.
• W3004603875 cites W2036321220 @default.
• W3004603875 cites W2036813543 @default.
• W3004603875 cites W2040022677 @default.
• W3004603875 cites W2056322765 @default.
• W3004603875 cites W2071437006 @default.
• W3004603875 cites W2080752012 @default.
• W3004603875 cites W2090206737 @default.
• W3004603875 cites W2094008870 @default.
• W3004603875 cites W2107277218 @default.
• W3004603875 cites W2124254102 @default.
• W3004603875 cites W2133619107 @default.
• W3004603875 cites W2143963194 @default.
• W3004603875 cites W2152362765 @default.
• W3004603875 cites W2157305173 @default.
• W3004603875 cites W2162720854 @default.
• W3004603875 cites W2165174998 @default.
• W3004603875 cites W2170776626 @default.
• W3004603875 cites W2177352331 @default.
• W3004603875 cites W2192080449 @default.
• W3004603875 cites W2212640525 @default.
• W3004603875 cites W2228507732 @default.
• W3004603875 cites W2272715130 @default.
• W3004603875 cites W2276228008 @default.
• W3004603875 cites W2283064216 @default.
• W3004603875 cites W2283148074 @default.
• W3004603875 cites W2310968520 @default.
• W3004603875 cites W2319416797 @default.
• W3004603875 cites W2324097249 @default.
• W3004603875 cites W2338576041 @default.
• W3004603875 cites W2356301336 @default.
• W3004603875 cites W2400719370 @default.
• W3004603875 cites W2407627822 @default.
• W3004603875 cites W2409059310 @default.
• W3004603875 cites W2412923902 @default.
• W3004603875 cites W2501351815 @default.
• W3004603875 cites W2508367039 @default.
• W3004603875 cites W2509116245 @default.
• W3004603875 cites W2516702596 @default.
• W3004603875 cites W2519028131 @default.
• W3004603875 cites W2519828822 @default.
• W3004603875 cites W2585474788 @default.
• W3004603875 cites W2589371072 @default.
• W3004603875 cites W2592615376 @default.
• W3004603875 cites W2625144143 @default.
• W3004603875 cites W2736418886 @default.
• W3004603875 cites W2763970918 @default.
• W3004603875 cites W2773242491 @default.
• W3004603875 cites W2789761892 @default.
• W3004603875 cites W2791544564 @default.
• W3004603875 cites W2791923388 @default.
• W3004603875 cites W2794310103 @default.
• W3004603875 cites W2794930605 @default.
• W3004603875 cites W2801437236 @default.
• W3004603875 cites W2806234074 @default.
• W3004603875 cites W2808781256 @default.
• W3004603875 cites W2889646458 @default.
• W3004603875 cites W2914105091 @default.
• W3004603875 cites W2945529338 @default.
• W3004603875 doi "https://doi.org/10.18632/oncotarget.27462" @default.
• W3004603875 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7007292" @default.
• W3004603875 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32082487" @default.
• W3004603875 hasPublicationYear "2020" @default.
• W3004603875 type Work @default.
• W3004603875 sameAs 3004603875 @default.
• W3004603875 citedByCount "26" @default.
• W3004603875 countsByYear W30046038752020 @default.
• W3004603875 countsByYear W30046038752021 @default.

• next